{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:20:15Z","timestamp":1790886015795,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>In vitro<\/jats:italic>\n                    human ether-\u00e0-go-go related gene (hERG) inhibition assay alone might provide insufficient information to discriminate \u201csafe\u201d from \u201cdangerous\u201d drugs. Here, effects of multichannel inhibition on cardiac electrophysiology were investigated using a family of cardiac cell models (Purkinje (P), endocardial (Endo), mid-myocardial (M) and epicardial (Epi)). We found that: (1) QT prolongation alone might not necessarily lead to early afterdepolarization (EAD) events, and it might be insufficient to predict arrhythmogenic liability; (2) the occurrence and onset of EAD events could be a candidate biomarker of drug-induced arrhythmogenicity; (3) M cells are more vulnerable to drug-induced arrhythmias, and can develop early afterdepolarization (EAD) at slower pacing rates; (4) the application of quinidine can cause EADs in all cell types, while I\n                    <jats:sub>NaL<\/jats:sub>\n                    is the major depolarizing current during the generation of drug-induced EAD in P cells, I\n                    <jats:sub>CaL<\/jats:sub>\n                    is mostly responsible in other cell types; (5) drug-induced action potential (AP) alternans with beat-to-beat variations occur at high pacing rates in P cells. These results suggested that quantitative profiling of transmural and rate-dependent properties can be essential to evaluate drug-induced arrhythmogenic risks, and may provide mechanistic insights into drug-induced arrhythmias.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-55032-x","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T06:02:54Z","timestamp":1575612174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transmural and rate-dependent profiling of drug-induced arrhythmogenic risks through in silico simulations of multichannel pharmacology"],"prefix":"10.1038","volume":"9","author":[{"given":"Ping\u2019an","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"55032_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bmj.319.7201.7a","volume":"319","author":"S Gottlieb","year":"1999","unstructured":"Gottlieb, S. Antihistamine drug withdrawn by manufacturer. BMJ 319, 7 (1999).","journal-title":"BMJ"},{"issue":"7076","key":"55032_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/bmj.314.7076.247c","volume":"314","author":"D. Josefson","year":"1997","unstructured":"Josefson, D. Hay fever drug to be banned by the FDA. BMJ (314:248) (1997).","journal-title":"BMJ"},{"key":"55032_CR3","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1001\/jama.283.17.2228-JFD00003-2-1","volume":"283","author":"JE Henney","year":"2000","unstructured":"Henney, J. E. Withdrawal of troglitazone and cisapride. JAMA 283, 2228 (2000).","journal-title":"JAMA"},{"key":"55032_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap, Y. G. Drug induced QT prolongation and torsades de pointes. Heart 89, 1363\u20131372) (2003).","journal-title":"Heart"},{"key":"55032_CR5","unstructured":"International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice. (Fed Regist ;70:61133\u201361134) (2005)."},{"key":"55032_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/s0008-6363(02)00846-5","volume":"58","author":"W Redfern","year":"2003","unstructured":"Redfern, W. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovascular Research 58, 32\u201345, https:\/\/doi.org\/10.1016\/s0008-6363(02)00846-5 (2003).","journal-title":"Cardiovascular Research"},{"key":"55032_CR7","doi-asserted-by":"publisher","first-page":"22710","DOI":"10.1073\/pnas.1016300108","volume":"107","author":"JD Osteen","year":"2010","unstructured":"Osteen, J. D. et al. KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gate. Proc Natl Acad Sci USA 107, 22710\u201322715, https:\/\/doi.org\/10.1073\/pnas.1016300108 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"55032_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jacc.2009.10.033","volume":"55","author":"G Antoons","year":"2010","unstructured":"Antoons, G. et al. Late Na+ current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model. J Am Coll Cardiol 55, 801\u2013809, https:\/\/doi.org\/10.1016\/j.jacc.2009.10.033 (2010).","journal-title":"J Am Coll Cardiol"},{"key":"55032_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/CIRCEP.111.963025","volume":"5","author":"DM Johnson","year":"2012","unstructured":"Johnson, D. M., de Jong, M. M., Crijns, H. J., Carlsson, L. G. & Volders, P. G. Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts. Circ Arrhythm Electrophysiol 5, 201\u2013209, https:\/\/doi.org\/10.1161\/CIRCEP.111.963025 (2012).","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"55032_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep02100","volume":"3","author":"J Kramer","year":"2013","unstructured":"Kramer, J. et al. MICE models: superior to the HERG model in predicting Torsade de Pointes. Sci Rep 3, 2100, https:\/\/doi.org\/10.1038\/srep02100 (2013).","journal-title":"Sci Rep"},{"key":"55032_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","volume":"167","author":"PT Sager","year":"2014","unstructured":"Sager, P. T., Gintant, G., Turner, J. R., Pettit, S. & Stockbridge, N. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. Am Heart J 167, 292\u2013300, https:\/\/doi.org\/10.1016\/j.ahj.2013.11.004 (2014).","journal-title":"Am Heart J"},{"key":"55032_CR12","doi-asserted-by":"publisher","unstructured":"Ellermann, C. et al. Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation. Cardiovasc Toxicol, https:\/\/doi.org\/10.1007\/s12012-019-09533-w (2019).","DOI":"10.1007\/s12012-019-09533-w"},{"key":"55032_CR13","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/bjp.2008.123","volume":"154","author":"AA Fossa","year":"2008","unstructured":"Fossa, A. A. The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol 154, 1508\u20131515, https:\/\/doi.org\/10.1038\/bjp.2008.123 (2008).","journal-title":"Br J Pharmacol"},{"key":"55032_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/bph.13391","volume":"173","author":"P Champeroux","year":"2016","unstructured":"Champeroux, P. et al. The high frequency relationship: implications for torsadogenic hERG blockers. Br J Pharmacol 173, 601\u2013612, https:\/\/doi.org\/10.1111\/bph.13391 (2016).","journal-title":"Br J Pharmacol"},{"key":"55032_CR15","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1109\/IEMBS.2009.5332708","volume":"2009","author":"RC Kerckhoffs","year":"2009","unstructured":"Kerckhoffs, R. C. et al. Multi-scale modeling of excitation-contraction coupling in the normal and failing heart. Conf Proc IEEE Eng Med Biol Soc 2009, 4281\u20134282, https:\/\/doi.org\/10.1109\/IEMBS.2009.5332708 (2009).","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"55032_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep37948","volume":"6","author":"JY Le Guennec","year":"2016","unstructured":"Le Guennec, J. Y. et al. Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety? Sci Rep 6, 37948, https:\/\/doi.org\/10.1038\/srep37948 (2016).","journal-title":"Sci Rep"},{"key":"55032_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.vascn.2008.05.007","volume":"58","author":"JP Valentin","year":"2008","unstructured":"Valentin, J. P. & Hammond, T. Safety and secondary pharmacology: successes, threats, challenges and opportunities. J Pharmacol Toxicol Methods 58, 77\u201387, https:\/\/doi.org\/10.1016\/j.vascn.2008.05.007 (2008).","journal-title":"J Pharmacol Toxicol Methods"},{"key":"55032_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2165\/11591950-000000000-00000","volume":"34","author":"K Fletcher","year":"2011","unstructured":"Fletcher, K. et al. Novel approaches to assessing cardiac safety\u2013proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs. Drug Saf 34, 439\u2013443, https:\/\/doi.org\/10.2165\/11591950-000000000-00000 (2011).","journal-title":"Drug Saf"},{"key":"55032_CR19","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1476-5381.2012.02020.x","volume":"167","author":"GR Mirams","year":"2012","unstructured":"Mirams, G. R., Davies, M. R., Cui, Y., Kohl, P. & Noble, D. Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing. Br J Pharmacol 167, 932\u2013945, https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02020.x (2012).","journal-title":"Br J Pharmacol"},{"key":"55032_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cvr\/cvr044","volume":"91","author":"GR Mirams","year":"2011","unstructured":"Mirams, G. R. et al. Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk. Cardiovasc Res 91, 53\u201361, https:\/\/doi.org\/10.1093\/cvr\/cvr044 (2011).","journal-title":"Cardiovasc Res"},{"key":"55032_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/cpt.367","volume":"100","author":"MC Lancaster","year":"2016","unstructured":"Lancaster, M. C. & Sobie, E. A. Improved Prediction of Drug-Induced Torsades de Pointes Through Simulations of Dynamics and Machine Learning Algorithms. Clin Pharmacol Ther 100, 371\u2013379, https:\/\/doi.org\/10.1002\/cpt.367 (2016).","journal-title":"Clin Pharmacol Ther"},{"key":"55032_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1021\/acs.jcim.7b00440","volume":"58","author":"L Romero","year":"2018","unstructured":"Romero, L. et al. In Silico QT and APD Prolongation Assay for Early Screening of Drug-Induced Proarrhythmic Risk. J Chem Inf Model 58, 867\u2013878, https:\/\/doi.org\/10.1021\/acs.jcim.7b00440 (2018).","journal-title":"J Chem Inf Model"},{"key":"55032_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.vascn.2016.08.007","volume":"83","author":"T Kubo","year":"2017","unstructured":"Kubo, T., Ashihara, T., Tsubouchi, T. & Horie, M. Significance of integrated in silico transmural ventricular wedge preparation models of human non-failing and failing hearts for safety evaluation of drug candidates. J Pharmacol Toxicol Methods 83, 30\u201341, https:\/\/doi.org\/10.1016\/j.vascn.2016.08.007 (2017).","journal-title":"J Pharmacol Toxicol Methods"},{"key":"55032_CR24","first-page":"49","volume":"31","author":"HP Fischer","year":"2008","unstructured":"Fischer, H. P. Mathematical modeling of complex biological systems: from parts lists to understanding systems behavior. Alcohol Res Health 31, 49\u201359 (2008).","journal-title":"Alcohol Res Health"},{"key":"55032_CR25","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.hrthm.2019.01.034","volume":"16","author":"AAM Wilde","year":"2019","unstructured":"Wilde, A. A. M., Garan, H. & Boyden, P. A. Role of the Purkinje system in heritable arrhythmias. Heart Rhythm 16, 1121\u20131126, https:\/\/doi.org\/10.1016\/j.hrthm.2019.01.034 (2019).","journal-title":"Heart Rhythm"},{"key":"55032_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1536\/jhj.40.609","volume":"40","author":"M Kondo","year":"1999","unstructured":"Kondo, M. & Tsutsumi, T. Potassium channel openers antagonize the effects of class III antiarrhythmic agents in canine Purkinje fiber action potentials. Implications for prevention of proarrhythmia induced by class III agents. Jpn Heart J 40, 609\u2013619 (1999).","journal-title":"Jpn Heart J"},{"key":"55032_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/00005344-198601000-00026","volume":"8","author":"A Varro","year":"1986","unstructured":"Varro, A., Nakaya, Y. & Elharrar, V. Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol 8, 178\u2013185 (1986).","journal-title":"J Cardiovasc Pharmacol"},{"key":"55032_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCRESAHA.111.246512","volume":"109","author":"P Li","year":"2011","unstructured":"Li, P. & Rudy, Y. A model of canine purkinje cell electrophysiology and Ca2+ cycling: rate dependence, triggered activity, and comparison to ventricular myocytes. Circ Res 109, 71\u201379, https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.246512 (2011).","journal-title":"Circ Res"},{"key":"55032_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0002-8703(84)90081-4","volume":"107","author":"JL Bauman","year":"1984","unstructured":"Bauman, J. L. et al. Torsade de pointes due to quinidine: observations in 31 patients. Am Heart J 107, 425\u2013430, https:\/\/doi.org\/10.1016\/0002-8703(84)90081-4 (1984).","journal-title":"Am Heart J"},{"key":"55032_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ccep.2016.02.011","volume":"8","author":"M Shenasa","year":"2016","unstructured":"Shenasa, M., Assadi, H., Heidary, S. & Shenasa, H. Ranolazine: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias. Card Electrophysiol Clin 8, 467\u2013479, https:\/\/doi.org\/10.1016\/j.ccep.2016.02.011 (2016).","journal-title":"Card Electrophysiol Clin"},{"key":"55032_CR31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.hrthm.2011.01.026","volume":"8","author":"LD Wilson","year":"2011","unstructured":"Wilson, L. D., Jennings, M. M. & Rosenbaum, D. S. Point: M cells are present in the ventricular myocardium. Heart Rhythm 8, 930\u2013933, https:\/\/doi.org\/10.1016\/j.hrthm.2011.01.026 (2011).","journal-title":"Heart Rhythm"},{"key":"55032_CR32","doi-asserted-by":"publisher","first-page":"e1003543","DOI":"10.1371\/journal.pcbi.1003543","volume":"10","author":"MA Cummins","year":"2014","unstructured":"Cummins, M. A., Dalal, P. J., Bugana, M., Severi, S. & Sobie, E. A. Comprehensive analyses of ventricular myocyte models identify targets exhibiting favorable rate dependence. PLoS Comput Biol 10, e1003543, https:\/\/doi.org\/10.1371\/journal.pcbi.1003543 (2014).","journal-title":"PLoS Comput Biol"},{"key":"55032_CR33","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.hrthm.2010.09.017","volume":"7","author":"JN Weiss","year":"2010","unstructured":"Weiss, J. N., Garfinkel, A., Karagueuzian, H. S., Chen, P. S. & Qu, Z. Early afterdepolarizations and cardiac arrhythmias. Heart Rhythm 7, 1891\u20131899, https:\/\/doi.org\/10.1016\/j.hrthm.2010.09.017 (2010).","journal-title":"Heart Rhythm"},{"key":"55032_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1472-8206.1993.tb00215.x","volume":"7","author":"J Weissenburger","year":"1993","unstructured":"Weissenburger, J., Davy, J. M. & Chezalviel, F. Experimental models of torsades de pointes. Fundam Clin Pharmacol 7, 29\u201338, https:\/\/doi.org\/10.1111\/j.1472-8206.1993.tb00215.x (1993).","journal-title":"Fundam Clin Pharmacol"},{"key":"55032_CR35","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1161\/01.cir.103.23.2851","volume":"103","author":"GX Yan","year":"2001","unstructured":"Yan, G. X. et al. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 103, 2851\u20132856, https:\/\/doi.org\/10.1161\/01.cir.103.23.2851 (2001).","journal-title":"Circulation"},{"key":"55032_CR36","doi-asserted-by":"publisher","first-page":"H689","DOI":"10.1152\/ajpheart.2001.281.2.H689","volume":"281","author":"AC Zygmunt","year":"2001","unstructured":"Zygmunt, A. C. et al. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol Heart Circ Physiol 281, H689\u201397 (2001).","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl 1","key":"55032_CR37","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1111\/j.1540-8167.2006.00388.x","volume":"17","author":"C Antzelevitch","year":"2006","unstructured":"Antzelevitch, C. & Belardinelli, L. The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis. J Cardiovasc Electrophysiol 17(Suppl 1), S79\u2013S85, https:\/\/doi.org\/10.1111\/j.1540-8167.2006.00388.x (2006).","journal-title":"J Cardiovasc Electrophysiol"},{"key":"55032_CR38","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.hrthm.2016.11.036","volume":"14","author":"W Li","year":"2017","unstructured":"Li, W. et al. Larger rate dependence of late sodium current in cardiac Purkinje cells: A potential link to arrhythmogenesis. Heart Rhythm 14, 422\u2013431, https:\/\/doi.org\/10.1016\/j.hrthm.2016.11.036 (2017).","journal-title":"Heart Rhythm"},{"key":"55032_CR39","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.res.86.4.448","volume":"86","author":"PA Boyden","year":"2000","unstructured":"Boyden, P. A., Pu, J., Pinto, J. & Keurs, H. E. Ca2+ transients and Ca2+ waves in purkinje cells: role in action potential initiation. Circ Res 86, 448\u2013455, https:\/\/doi.org\/10.1161\/01.res.86.4.448 (2000).","journal-title":"Circ Res"},{"key":"55032_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10840-018-0414-3","volume":"52","author":"PA Boyden","year":"2018","unstructured":"Boyden, P. A. Purkinje physiology and pathophysiology. J Interv Card Electrophysiol 52, 255\u2013262, https:\/\/doi.org\/10.1007\/s10840-018-0414-3 (2018).","journal-title":"J Interv Card Electrophysiol"},{"key":"55032_CR41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/304735a0","volume":"304","author":"CH Orchard","year":"1983","unstructured":"Orchard, C. H., Eisner, D. A. & Allen, D. G. Oscillations of intracellular Ca2+ in mammalian cardiac muscle. Nature 304, 735\u2013738, https:\/\/doi.org\/10.1038\/304735a0 (1983).","journal-title":"Nature"},{"key":"55032_CR42","doi-asserted-by":"publisher","first-page":"H1017","DOI":"10.1152\/ajpheart.01216.2008","volume":"296","author":"KF Decker","year":"2009","unstructured":"Decker, K. F., Heijman, J., Silva, J. R., Hund, T. J. & Rudy, Y. Properties and ionic mechanisms of action potential adaptation, restitution, and accommodation in canine epicardium. Am J Physiol Heart Circ Physiol 296, H1017\u20131026, https:\/\/doi.org\/10.1152\/ajpheart.01216.2008 (2009).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"55032_CR43","doi-asserted-by":"publisher","first-page":"e004628","DOI":"10.1161\/CIRCEP.116.004628","volume":"10","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-a-go-go-Related Gene) Channel-Drug Binding Kinetics and Multichannel Pharmacology. Circ Arrhythm Electrophysiol 10, e004628, https:\/\/doi.org\/10.1161\/CIRCEP.116.004628 (2017).","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"55032_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/sj.bjp.0706070","volume":"144","author":"P Champeroux","year":"2005","unstructured":"Champeroux, P. et al. Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres. Br J Pharmacol 144, 376\u2013385, https:\/\/doi.org\/10.1038\/sj.bjp.0706070 (2005).","journal-title":"Br J Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55032-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:02:04Z","timestamp":1671278524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55032-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55032"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55032-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/752998","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18504"}}